发明名称 |
Novel NIDDM regimen |
摘要 |
The present invention relates to the use of a short-acting oral hypoglycemic agent and to a novel regimen in the treatment of type 2 diabetes in which the endogenous secretion of insulin is stimulated in connection with meals by administering in connection with the meals a short-acting oral hypoglycaemic agent. Also, the present invention relates to a method of achieving significantly improvement in the glycaemic control by a combined use of repaglinide and metformin in NIDDM patients poorly controlled on metformin alone.
|
申请公布号 |
US2005222262(A1) |
申请公布日期 |
2005.10.06 |
申请号 |
US20050137864 |
申请日期 |
2005.05.26 |
申请人 |
HEMMINGSEN LISBETH T;MULLER PETER G |
发明人 |
HEMMINGSEN LISBETH T.;MULLER PETER G. |
分类号 |
A61K31/155;A61K31/198;(IPC1-7):A61K31/198 |
主分类号 |
A61K31/155 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|